T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Gibraltar Industries
ROCK
$1.47B
| $38.2M | 0.01% |
2,348,805
+25,200
| +1% | +$373K |
|
|
CSOD
927
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $38.1M | 0.01% |
1,081,072
+191,862
| +22% | +$6.34M |
|
928
Cadence Design Systems
CDNS
$89.7B
| $38M | 0.01% |
2,004,499
-182,498
| -8% | -$3.28M |
|
929
Compass Diversified
CODI
$928M
| $37.8M | 0.01% |
2,327,778
-19,600
| -0.8% | -$339K |
|
930
Hasbro
HAS
$13.5B
| $37.6M | 0.01% |
683,852
-315,960
| -32% | -$17.8M |
|
|
MIG
931
DELISTED
MEADOWBROOK INSURANCE GRP INC
MIG
| $37.4M | 0.01% |
4,419,242
-227,461
| -5% | -$1.43M |
|
|
COL
932
DELISTED
Rockwell Collins
COL
| $37.4M | 0.01% |
442,443
-13,575
| -3% | -$1.11M |
|
933
Edwards Lifesciences
EW
$53.5B
| $37.2M | 0.01% |
1,751,010
+37,860
| +2% | +$761K |
|
934
Hershey
HSY
$37.3B
| $37.1M | 0.01% |
357,121
-3,690
| -1% | -$359K |
|
|
DF
935
DELISTED
Dean Foods Company
DF
| $37.1M | 0.01% |
1,913,738
-2,669,900
| -58% | -$42.5M |
|
936
Jack Henry & Associates
JKHY
$10.8B
| $37M | 0.01% |
594,741
-963,767
| -62% | -$57.5M |
|
937
HEICO Corp Class A
HEI.A
$37.6B
| $36.8M | 0.01% |
1,899,487
-1,404,053
| -43% | -$25.6M |
|
|
CCI.PRA
938
DELISTED
Crown Castle International Corp.
CCI.PRA
| $36.7M | 0.01% |
361,552
-24,975
| -6% | -$2.58M |
|
939
Mueller Water Products
MWA
$4.05B
| $36.6M | 0.01% |
3,574,837
+28,400
| +0.8% | +$269K |
|
940
Preferred Bank
PFBC
$1.28B
| $36.6M | 0.01% |
1,312,208
+47,915
| +4% | +$1.22M |
|
|
NCI
941
DELISTED
Navigant Consulting, Inc.
NCI
| $36.5M | 0.01% |
2,376,410
-32,400
| -1% | -$470K |
|
942
PennyMac Financial
PFSI
$4.12B
| $36.5M | 0.01% |
2,110,855
+11,905
| +0.6% | +$190K |
|
|
ASCMA
943
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $36.5M | 0.01% |
689,138
-266,517
| -28% | -$15.3M |
|
944
Hawkins
HWKN
$2.72B
| $36.5M | 0.01% |
1,683,022
+400
| +0% | +$7.77K |
|
945
Bread Financial
BFH
$4.47B
| $36.5M | 0.01% |
159,670
+21,889
| +16% | +$4.79M |
|
946
Community Health Systems
CYH
$412M
| $36.4M | 0.01% |
817,884
-13,794
| -2% | -$590K |
|
947
Astec Industries
ASTE
$989M
| $36.3M | 0.01% |
922,790
-10,600
| -1% | -$401K |
|
|
SINA
948
DELISTED
Sina Corp
SINA
| $36.2M | 0.01% |
968,100
-3,800
| -0.4% | -$148K |
|
949
WIX.com
WIX
$3.05B
| $36.1M | 0.01% |
1,717,943
-468,062
| -21% | -$8.93M |
|
950
Coca-Cola Consolidated
COKE
$12.7B
| $36M | 0.01% |
4,088,700
-47,200
| -1% | -$407K |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.